Severity
Moderate
ModerateActive
CPSC recall · Reported April 25, 2019
TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning (Recall Alert)
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children …
TriDerma, of Corona, Calif. recalled This recall involves TriDerma Pain Relief Cream with 4% Lidocaine in a jar and tube. The … — a moderate-severity action.
TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Require… was recalled by TriDerma, of Corona, Calif. in April 25, 2019. Reason: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving c…. Remedy: Consumers should immediately store the topical anesthetic in a safe location, out of reac…. Verify recall #19742 with the CPSC before acting.
The recall
TriDerma, of Corona, Calif. issued this moderate-severity CPSC recall — The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving c….
- Moderate
- severity level
- April 25, 2019
- reported
Sourced from official CPSC enforcement records. Verify recall #19742 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This CPSC action (record #19742) was formally reported on April 25, 2019. It is classified under Moderate severity, with a current status of Active. TriDerma, of Corona, Calif. is listed as the recalling firm. Federal records list the affected scope as About 410.
The documented reason for this recall is: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest i… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all know… — consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Children & Baby Products recalls over time
Where this recall sits in its category — 3,146 children & baby products recalls on record
Where this recall sits in the database
Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.
Affected scope
About 410
Related Recalls
6
0 from same agency
Product description
This recall involves TriDerma Pain Relief Cream with 4% Lidocaine in a jar and tube. The 4 ounce jar is white with a lime green and pink printed label and has a white dome cap. The 2.2 ounce tube is white with a lime green and pink printed label. The lot numbers and expiration dates of the affected products can be found on the bottom of the jar and on the front of the crimped end of the tube. "TriDerma Pain Relief Cream" is printed on the jar and tube. Lot Number Expiration Date 21088 04/2021 20189 04/2021 0738F02A 06/2021 0738F04A 06/2021 0738F04B 06/2021 0738F04C 06/2021 0739A22A 01/2022 0739A22B 01/2022 0739A23A 01/2022
Reason for recall
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Remedy — what to do
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 19742 |
| Date reported | April 25, 2019 |
| Date initiated | April 25, 2019 |
| Recalling firm | TriDerma, of Corona, Calif. |
| Affected scope | About 410 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a…
- Check the recall number (19742) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
This recall involves TriDerma Pain Relief Cream with 4% Lidocaine in a jar and tube. The 4 ounce jar is white with a lime green and pink printed label and has a white dome cap. The 2.2 ounce tube is white with a lime green and pink printed label. The lot numbers and expiration dates of the affected products can be found on the bottom of the jar and on the front of the crimped end of the tube. "TriDerma Pain Relief Cream" is printed on the jar and tube. Lot Number Expiration Date 21088 04/2021 20189 04/2021 0738F02A 06/2021 0738F04A 06/2021 0738F04B 06/2021 0738F04C 06/2021 0739A22A 01/2022 0739A22B 01/2022 0739A23A 01/2022. Recalled by TriDerma, of Corona, Calif.. Units affected: About 410.
Why was this product recalled? ▼
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
What should consumers do? ▼
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
Which agency issued this recall? ▼
This recall was issued by the CPSC on April 25, 2019. Severity: Moderate. Recall number: 19742.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (19742) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.
Continue exploring
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
CPSC recalls
Every recall issued by CPSC, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Nearby Recalls in This Category
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
FDA Food Critical
Wawa Diet Iced Tea Lemon Pint (16oz),Plastic bottle
Wawa Beverage Company · 2026-06-03
FDA Food Critical
Wawa Diet Lemonade Pint (16oz), Plastic bottle
Wawa Beverage Company · 2026-06-03
FDA Food Critical
Wawa Iced Tea Lemon 16 oz Pint, Plastic bottle
Wawa Beverage Company · 2026-06-03
FDA Food Moderate
Liposomal Sleep Spray. Dosage: 6 sprays Liquid. Packaging: Aluminum bottle. 30 ml. Firm Address: VitaminAlly LLC Chandl…
Wellnov Supplements LLC · 2026-05-27
FDA Food Moderate
Liposomal B12 Spray. Dosage: 3 sprays Liquid. Packaging: Aluminum bottle. 30 ml. Firm Address: VitaminAlly LLC Chandler…
Wellnov Supplements LLC · 2026-05-27
Compare this recall with Wawa Diet Iced Tea Lemon Pint (16oz),Plastic bottle →
Data Sources
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: CPSC, reported April 25, 2019.
- Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
- Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
- Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.